PRCISR™ CRISPR Libraries & Screening Services
Drug target discovery across various diseases
Research/DiscoveryActive
Key Facts
Indication
Drug target discovery across various diseases
Phase
Research/Discovery
Status
Active
Company
About Vivlion
Vivlion is a private, pre-revenue platform company developing next-generation CRISPR screening tools through its proprietary 3Cs (Covalently-Closed-Circular-synthesized) manufacturing technology. This technology addresses critical limitations of conventional library production by eliminating PCR-induced bias, resulting in libraries with superior uniformity and completeness. The company's offerings include single and combinatorial sgRNA libraries, as well as full-service screening and bioinformatics, enabling more efficient genetic screens with less cell material. Vivlion's platform is positioned to enhance target discovery across various therapeutic areas, particularly in oncology.
View full company profile